Earlier onset of alzheimer's disease: Risk polymorphisms within PRNP, PRND, CYP46, and APOE genes

Journal of Alzheimer's Disease

Volumn 17, Issue 2, 2009, Pages 359-368

  Golanska, Ewa ^a   Hulas Bigoszewska, Krystyna ^a   Sieruta, Monika ^a   Zawlik, Izabela ^a   Witusik, Monika ^a   Gresner, Sylwia M ^a   Sobow, Tomasz ^a   Styczynska, Maria ^b   Peplonska, Beata ^b   Barcikowska, Maria ^b   Liberski, Pawel P ^a   Corder, Elizabeth H ^c  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c Matrix Genomics Inc   (United States)

Author keywords

Alzheimer's disease; APOE; CYP46; Genetic polymorphisms; Grade of membership analysis; Multiple genetic risk factors; PRND; PRNP

Indexed keywords

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; APOE GENE; ARTICLE; CONTROLLED STUDY; CYP46 GENE; FEMALE; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PRND GENE; PRNP GENE;

EID: 67849104137     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2009-1055     Document Type: Article

References (46)

1. Bertram L, McQueen MB, Mullin K, Blacker D, Tanzi RE (2007) Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat Genet 39, 17-23. Available at: http://www.alzgene. org
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261, 921-923.
3. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crapper-MacLachlan DR, Alberts MJ, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
4. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell Jr PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE, et al. (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7, 180-184.
5. Combarros O, Cortina-Borja M, Smith AD, Lehmann DJ (2009) Epistasis in sporadic Alzheimer's disease. Neurobiol Aging, in press.
6. Prince JA, Feuk L, Sawyer SL, Gottfries J, Ricksten A, Nagga K, Bogdanovic N, Blennow K, Brookes AJ (2001) Lack of replication of association findings in complex disease: an analysis of 15 polymorphisms in prior candidate genes for sporadic Alzheimer's disease. Eur J Hum Genet 9, 437-444.
7. Brown P, Preece M, Brandel JP, Sato T, McShane L, Zerr I, Fletcher A, Will RG, Pocchiari M, Cashman NR, d'Aignaux JH, Cervená colonkovaampersandacute; L, Fradkin J, Schonberger LB, Collins SJ (2000) Iatrogenic Creutzfeldt-Jakob disease at the millenium. Neurology 55, 1075-1081.
8. Mead S, Mahal SP, Beck J, Campbell T, Farrall M, Fisher E, Collinge J(2001) Sporadic - but not variant-Creutzfeldt-Jakob Disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet 69, 1225-1235.
9. Ironside JW, Head MW (2004) Neuropathology and molecular biology of variant Creutzfeldt-Jakob Disease. Curr Top Microbiol Immunol 284, 133-159.
10. Berr C, Richard F, Dufouil C, Amant C, Alperovitch A, Amouyel P (1998) Polymorphism of the prion protein is associated with cognitive impairment in the elderly: the EVA study. Neurology 51, 734-737.
11. Berr C, Helbecque N, Sazdovitch V, Mohr M, Amant C, Amouyel P, Alperovitch A, Hauw JJ (2003) Polymorphism of the codon 129 of the prion protein (PrP) gene and neuropathology of cerebral ageing. Acta Neuropathol 106, 71-74.
12. Riemenschneider M, Klopp N, Xiang W, Wagenpfeil S, Vollmert C, Müller U, Förstl H, Illig T, Kretzschmar H, Kurz A (2004) Prion protein codon 129 polymorphism and risk for Alzheimer disease. Neurology 63, 364-366.
13. Jeong BH, Lee KH, Jeong YE, Hwang KA, Lee YJ, Carp RI, Ju YR, Kim YS (2007) Polymorphisms at codons 129 and 219 of the prion protein gene (PRNP) are not associated with sporadic Alzheimer's disease in the Korean population. Eur J Neurol 14, 621-626.
14. Behrens A, Genoud N, Naumann H, Riilicke T, Janett F, Hep- pner FL, Ledermann B, Aguzzi A (2002) Absence of the prion protein homologue Doppel causes male sterility. EMBO J 21, 3652-3658.
15. Rossi D, Cozzio A, Flechsig E, Klein MA, Rulicke T, Aguzzi A (2001) Onset of ataxia and Purkinje cell loss in PrP null mice inversely correlated with Dpl level in brain. EMBO J 20, 694-702.
16. Croes EA, Alizadeh BZ, Bertoli-Avella AM, Rademaker T, Vergeer-Drop J, Dermaut B, Houwing-Duistermaat JJ, Wientjens DP, Hof man A, Van Broeckhoven C, van Duijn CM (2004) Polymorphisms in the prion protein gene and its doppel increase susceptibility for Creutzfeldt-Jakob disease. Eur JHum Genet 12, 389-394.
17. Jeong BH, Kim NH, Kim JI, Carp RI, Kim YS (2005) Polymorphisms at codons 56 and 174 of the prion-like protein gene (PRND) are not associated with sporadic Creutzfeldt-Jakob disease. J Hum Genet 50, 311-314.
18. Ferrer I, Freixas M, Blanco R, Carmona M, Puig B (2004) Selective PrP-like protein, doppel immunoreactivity in dystrophic neuritis of senile plaques in Alzheimer's disease. Neuropathol Appl Neurobiol 30, 329-337.
19. Infante J, Llorca J, Rodero L, Palacio E, Berciano J, Combar- ros O (2002) Polymorphism at codon 174 of the prion-like protein gene is not associated with sporadic Alzheimer's disease. Neurosci Lett 332, 213-215.
20. Golanska E, Hulas-Bigoszewska K, Rutkiewicz E, Styczynska M, Peplonska B, Barcikowska M, Bratosiewicz-Wasik J, Liberski PP (2004) Polymorphisms within the prion (PrP) and prion-like protein (Doppel) genes in AD. Neurology 62, 313315.
21. Bjorkhem I (2006) Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. J Intern Med 260, 493-508.
22. Fernandez Del Pozo V, Alvarez Alvarez M, Fernandez Martinez M, Galdoos Alcelay L, Gomez Busto F, Pena JA, Alfonso-Sanchez MA, Zarranz Imirizaldu JJ, de Pancorbo MM (2006) Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease. Dement Geriatr Cogn Disord 21, 81-87.
23. Golanska E, Hulas-Bigoszewska K, Wojcik I, Rieske P, Styczynska M, Peplonska B, Pfeffer A, Luczywek E, Wasiak B, Gabryelewicz T, Religa D, Chodakowska-Zebrowska M, Bar- cikowska M, Sobow T, Liberski PP (2005) CYP46: a risk factor for Alzheimer's disease or a coincidence? Neurosci Lett 383, 105-108.
24. Shibata N, Kawarai T, Lee JH, Lee HS, Shibata E, Sato C, Liang Y, Duara R, Mayeux RP, St George-Hyslop PH, Rogaeva E (2006) Association studies of cholesterol metabolism genes (CH25H, ABCA1 and CH24H) in Alzheimer's disease. NeurosciLett 391, 142-146.
25. Wang F, Jia J (2007) Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese. Brain Res 1147, 34-38.
26. Woodbury MA, Clive J (1974) Clinical pure types as a fuzzy partition. J Cybernetics 4, 111-121.
27. Woodbury MA, Clive J, Garson A (1978) Mathematical typology: a grade of membership technique for obtaining disease definition. Comp Biomed Res 11, 277-298.
28. Chapman J, Estupinan J, Asherov A, Goldfarb LG (1996) A simple and efficient method for apolipoprotein E genotype determination. Neurology 46, 1484-1485.
29. Corder EH, Beaumont H (2007) Susceptibility groups for Alzheimer's disease (OPTIMA cohort): Integration of gene variants and biochemical factors. Mech Ageing Dev 128, 76-82.
30. Corder EH, Blennow K, Prince JA (2008) Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci. Rejuvenation Res 11, 667-679.
31. Licastro F, Porcellini E, Caruso C, Lio D, Corder EH (2007) Genetic risk prof iles for Alzheimer's disease: Integration of APOE genotype and variants that up-regulate inflammation. Neurobiol Aging 28, 1637-1643.
32. Corder EH, Mellick GD (2006) Parkinson's disease in relation to pesticide exposure and nuclear encoded mitochondrial complex I gene variants. J Biomed Biotechnol 2006, 27601.
33. Corder EH, Hefler LA (2006) Multilocus genotypes spanning estrogen metabolism associated with breast cancer and fibroadenoma. Rejuvenation Res 9, 56-60.
34. Licastro F, Chiapelli M, Caldarera CM, Caruso C, Lio D, Corder EH (2007) Acute myocardial infarction and pro-inflammatory gene variants. Ann N YAcad Sci 1119, 227-242.
35. Dermaut B, Croes EA, Rademakers R, Van den Broeck M, Cruts M, Hof man A, van Duijn CM, Van Broeckhoven C (2003) PRNP Val129 homozygosity increases risk for early- onset Alzheimer's disease. Ann Neurol 53, 409-412.
36. Casadei VM, Ferri C, Calabrese E, Grimaldi LME (2001) Prion protein gene polymorphism and Alzheimer's disease: one modulatory trait of cognitive decline? J Neurol Neurosurg Psychiatry71, 279-280.
37. Del Bo R, Scarlato M, Ghezzi S, Martinelli-Boneschi F, Fenoglio C, Galimberti G, Galbiati S, Virgilio R, Galimberti D, Ferrarese C, Scarpini E, Bresolin N, Comi GP (2006) Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging27, 770.e1-770.e5.
38. Borroni B, Archetti S, Agosti C, Akkawi N, Brambilla C, Cai- mi L, Caltagirone C, Di Luca M, Padovani A (2004) Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer disease: from risk factors to disease modulators. Neurobiol Aging 25, 747-751.
39. Papassotiropoulos A, Streffer JR, Tsolaki M, Schmid S, Thal D, Nicosia F, Iakovidou V, Maddalena A, Lutjohann D, Ghebremedhin E, Hegi T, Pasch T, Traxler M, Bruhl A, Benussi L, Binetti G, Braak H, Nitsch RM, Hock C (2003) Increased brain //-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism. Arch Neurol 60, 29-35.
40. Juhasz A, Rimanooczy A, Boda K, Vincze G, Szlavik G, Zana M, Bjelik A, Pakaski M, Bodi N, Palotas A, Janka Z, Kalman J (2005) CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a populatio from Hungary. Neurochem Res 30, 943-948.
41. Wang B, Zhang C, Zheng W, Lu Z, Zheng C, Yang Z, Wang L, Jin F (2004) Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese. Neurosci Lett 369, 104-107.
42. Combarros O, Infante J, Llorca J, Berciano J (2004) Genetic association of CYP46 and risk for Alzheimer's disease. Dement Geriatr Cogn Disord 18, 257-260.
43. Wellington CL (2004) Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism. Clin Genet 66, 1-16.
44. Papassotiropoulos A, Wollmer MA, Tsolaki M, Brunner F, Molyva D, Lutjohann D, Nitsch RM, Hock C (2005) A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. J Clin Psychiatry 66, 940-947.
45. Gilch S, Kehler C, Schatzl HM (2006) The prion protein requires cholesterol for cell surface localization. Mol Cell Neurosci 31, 246-253.
46. Bate C, Salmona M, Diomede L, Williams A (2004) Squalestatin cures prion-infected neurons and protects against prion neurotoxicity. J Biol Chem 279, 14983-14990.